CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT/EQUITY - USD ($) $ in Thousands	Total	Series Seed Redeemable Convertible Preferred Stock	Series B Redeemable Convertible Preferred Stock	Series C Redeemable Convertible Preferred Stock	Common Equity	Additional Paid in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		81,790,144	105,595,101	119,599,872
Beginning balance at Dec. 31, 2023		$ 81,525	$ 121,148	$ 164,604
Ending balance (in shares) at Mar. 31, 2024		81,790,144	105,595,101	119,599,872
Ending balance at Mar. 31, 2024		$ 81,525	$ 121,148	$ 164,604
Beginning balance (in shares) at Dec. 31, 2023					640,386
Beginning balance at Dec. 31, 2023	$ (148,769)				$ 2	$ 4,250	$ (153,021)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)					37,836
Issuance of common stock upon exercise of stock options	50					50
Stock-based compensation	1,147					1,147
Net loss	(12,508)						(12,508)
Ending balance (in shares) at Mar. 31, 2024					678,222
Ending balance at Mar. 31, 2024	$ (160,080)				$ 2	5,447	(165,529)
Beginning balance (in shares) at Dec. 31, 2024	54,440,013				54,440,013
Beginning balance at Dec. 31, 2024	$ 491,875				$ 7	712,884	(221,016)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	88,962				88,962
Issuance of common stock upon exercise of stock options	$ 477					477
Stock-based compensation	3,451					3,451
Net loss	$ (36,846)						(36,846)
Ending balance (in shares) at Mar. 31, 2025	54,528,975				54,528,975
Ending balance at Mar. 31, 2025	$ 458,957				$ 7	$ 716,812	$ (257,862)